Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | CTSS | P25774 | 2/20 | 0.48 |
| ▸ | CTSK | P43235 | 2/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | BCL6 | P41182 | 1/20 | 0.46 |
| ▸ | GALR2 | O43603 | 3/20 | 0.44 |
| ▸ | GALR1 | P47211 | 3/20 | 0.44 |
| ▸ | CCR4 | P51679 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14421446 | 0.92 | CTSS (0.48) | SMN1; SMN2MAPTHTTNPSR1MEN1 | |
| SCHEMBL14472384 | 0.91 | SMN1; SMN2 (0.48) | SMN1; SMN2MAPTHTTNPSR1MEN1 | |
| SCHEMBL14533513 | 0.91 | CTSS (0.50) | SMN1; SMN2MAPTHTTNPSR1MEN1 | |
| SCHEMBL14533521 | 0.91 | RAB9A (0.58) | SMN1; SMN2MAPTHTTNPSR1MEN1 | |
| SCHEMBL14613060 | 0.90 | CTSS (0.50) | SMN1; SMN2MAPTHTTNPSR1MEN1 | |
| SCHEMBL14635367 | 0.88 | CTSS (0.45) | SMN1; SMN2MAPTHTTNPSR1MEN1 | |
| SCHEMBL14421462 | 0.88 | SMN1; SMN2 (0.45) | SMN1; SMN2MAPTHTTNPSR1MEN1 | |
| SCHEMBL14421461 | 0.87 | BCL6 (0.45) | SMN1; SMN2MAPTHTTNPSR1MEN1 | |
| SCHEMBL14421549 | 0.87 | SMN1; SMN2 (0.44) | SMN1; SMN2MAPTHTTNPSR1MEN1 | |
| SCHEMBL14421502 | 0.85 | SMN1; SMN2 (0.43) | SMN1; SMN2MAPTHTTNPSR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070122444-A1 | Medical devices employing triazine compounds and compositions thereof | DR. REDDY'S LABORATORIES LTD. (IN) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070122444-A1 | Medical devices employing triazine compounds and compositions thereof | AREG, TGFB1, TGFB2 | SMN1; SMN2 3890/4885MAPT 2787/4885HTT 573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.